BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 12105225)

  • 1. Phospholipid transfer protein deficiency protects circulating lipoproteins from oxidation due to the enhanced accumulation of vitamin E.
    Jiang XC; Tall AR; Qin S; Lin M; Schneider M; Lalanne F; Deckert V; Desrumaux C; Athias A; Witztum JL; Lagrost L
    J Biol Chem; 2002 Aug; 277(35):31850-6. PubMed ID: 12105225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in plasma vitamin E distribution in type 2 diabetic patients with elevated plasma phospholipid transfer protein activity.
    Schneider M; Vergès B; Klein A; Miller ER; Deckert V; Desrumaux C; Masson D; Gambert P; Brun JM; Fruchart-Najib J; Blache D; Witztum JL; Lagrost L
    Diabetes; 2004 Oct; 53(10):2633-9. PubMed ID: 15448094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels.
    Jiang XC; Bruce C; Mar J; Lin M; Ji Y; Francone OL; Tall AR
    J Clin Invest; 1999 Mar; 103(6):907-14. PubMed ID: 10079112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased atherosclerotic lesions in apoE mice with plasma phospholipid transfer protein overexpression.
    Yang XP; Yan D; Qiao C; Liu RJ; Chen JG; Li J; Schneider M; Lagrost L; Xiao X; Jiang XC
    Arterioscler Thromb Vasc Biol; 2003 Sep; 23(9):1601-7. PubMed ID: 12855484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phospholipid transfer protein gene knock-out mice have low high density lipoprotein levels, due to hypercatabolism, and accumulate apoA-IV-rich lamellar lipoproteins.
    Qin S; Kawano K; Bruce C; Lin M; Bisgaier C; Tall AR; Jiang X
    J Lipid Res; 2000 Feb; 41(2):269-76. PubMed ID: 10681411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma phospholipid transfer protein prevents vascular endothelium dysfunction by delivering alpha-tocopherol to endothelial cells.
    Desrumaux C; Deckert V; Athias A; Masson D; Lizard G; Palleau V; Gambert P; Lagrost L
    FASEB J; 1999 May; 13(8):883-92. PubMed ID: 10224231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevation of plasma phospholipid transfer protein increases the risk of atherosclerosis despite lower apolipoprotein B-containing lipoproteins.
    Lie J; de Crom R; van Gent T; van Haperen R; Scheek L; Sadeghi-Niaraki F; van Tol A
    J Lipid Res; 2004 May; 45(5):805-11. PubMed ID: 14993244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased prebeta-high density lipoprotein, apolipoprotein AI, and phospholipid in mice expressing the human phospholipid transfer protein and human apolipoprotein AI transgenes.
    Jiang X; Francone OL; Bruce C; Milne R; Mar J; Walsh A; Breslow JL; Tall AR
    J Clin Invest; 1996 Nov; 98(10):2373-80. PubMed ID: 8941656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phospholipid transfer protein deficiency impairs apolipoprotein-B secretion from hepatocytes by stimulating a proteolytic pathway through a relative deficiency of vitamin E and an increase in intracellular oxidants.
    Jiang XC; Li Z; Liu R; Yang XP; Pan M; Lagrost L; Fisher EA; Williams KJ
    J Biol Chem; 2005 May; 280(18):18336-40. PubMed ID: 15734742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Introduction of the human PLTP transgene suppresses the atherogenic diet-induced increase in plasma phospholipid transfer activity in C57BL/6 mice.
    Tu AY; Paigen B; Wolfbauer G; Cheung MC; Kennedy H; Chen H; Albers JJ
    Int J Clin Lab Res; 1999; 29(1):14-21. PubMed ID: 10356658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma phospholipid mass transfer rate: relationship to plasma phospholipid and cholesteryl ester transfer activities and lipid parameters.
    Cheung MC; Wolfbauer G; Albers JJ
    Biochim Biophys Acta; 1996 Sep; 1303(2):103-10. PubMed ID: 8856039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular and macromolecular specificity of human plasma phospholipid transfer protein.
    Rao R; Albers JJ; Wolfbauer G; Pownall HJ
    Biochemistry; 1997 Mar; 36(12):3645-53. PubMed ID: 9132017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux.
    Guerin M; Egger P; Soudant C; Le Goff W; van Tol A; Dupuis R; Chapman MJ
    Atherosclerosis; 2002 Aug; 163(2):287-96. PubMed ID: 12052475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver-specific phospholipid transfer protein deficiency reduces high-density lipoprotein and non-high-density lipoprotein production in mice.
    Yazdanyar A; Quan W; Jin W; Jiang XC
    Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2058-64. PubMed ID: 23846500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of phospholipid transfer protein on lipoprotein metabolism and atherosclerosis.
    Jiang XC
    Front Biosci; 2002 Jul; 7():d1634-41. PubMed ID: 12086920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of phospholipid transfer protein and cholesteryl ester transfer protein as contributors to the generation of pre beta-high-density lipoproteins.
    Lie J; de Crom R; Jauhiainen M; van Gent T; van Haperen R; Scheek L; Jansen H; Ehnholm C; van Tol A
    Biochem J; 2001 Dec; 360(Pt 2):379-85. PubMed ID: 11716766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenovirus mediated overexpression of human phospholipid transfer protein alters plasma HDL levels in mice.
    Ehnholm S; van Dijk KW; van 't Hof B; van der Zee A; Olkkonen VM; Jauhiainen M; Hofker M; Havekes L; Ehnholm C
    J Lipid Res; 1998 Jun; 39(6):1248-53. PubMed ID: 9643356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human plasma phospholipid transfer protein accelerates exchange/transfer of alpha-tocopherol between lipoproteins and cells.
    Kostner GM; Oettl K; Jauhiainen M; Ehnholm C; Esterbauer H; Dieplinger H
    Biochem J; 1995 Jan; 305 ( Pt 2)(Pt 2):659-67. PubMed ID: 7832785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transgenic mice expressing human phospholipid transfer protein have increased HDL/non-HDL cholesterol ratio.
    Albers JJ; Tu AY; Paigen B; Chen H; Cheung MC; Marcovina SM
    Int J Clin Lab Res; 1996; 26(4):262-7. PubMed ID: 9007618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex differences in atherosclerosis in mice with elevated phospholipid transfer protein activity are related to decreased plasma high density lipoproteins and not to increased production of triglycerides.
    Lie J; Moerland M; van Gent T; van Haperen R; Scheek L; Sadeghi-Niaraki F; de Crom R; van Tol A
    Biochim Biophys Acta; 2006 Sep; 1761(9):1070-7. PubMed ID: 16935026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.